One form of K2 lasts days
in your blood. The other
lasts a couple of hours.
MK-7 and MK-4 are both technically “vitamin K2” — and that’s about where the similarity ends. One stays active in your bloodstream for up to three days on a tiny once-a-day dose. The other clears out in a couple of hours, unless you take a lot more, a lot more often. That single difference — how long each one actually stays working — changes almost everything about which one belongs in a daily supplement.
What vitamin K2 actually does for you
Vitamin K2’s job is genuinely simple to explain: it tells your body where calcium should go. Once calcium is absorbed — largely thanks to vitamin D3 — K2 activates two specific proteins that direct it. One, osteocalcin, helps incorporate calcium into bone, supporting bone density. The other, matrix Gla protein, helps keep calcium out of your arteries and soft tissue, where it doesn’t belong. Without enough active K2, both of these direction-setting proteins stay switched off — meaning the calcium you’re absorbing isn’t necessarily ending up where you’d want it.
This is exactly why K2 gets paired so consistently with vitamin D3 in a well-formulated multivitamin — D3 controls how much calcium gets absorbed, and K2 controls where it goes once it’s in your bloodstream. One without the other is an incomplete story.
Why half-life is the whole story here
“Half-life” just means how long something stays at a meaningfully active level in your blood before it’s cleared out. This is the single number that explains almost every practical difference between MK-7 and MK-4.
MK-7 has a half-life of roughly three days. That means once you take it, it keeps circulating and staying active for an extended stretch — which is exactly why a small daily dose is enough to maintain a steady, working level day after day, without gaps.
MK-4 has a half-life of roughly one to two hours. It gets absorbed and used quickly — but it also clears out of your blood almost as fast. That means a dose taken in the morning is essentially gone by lunchtime, leaving nothing meaningfully active for the rest of the day unless you take another dose, and another, several times over.
“A short half-life doesn’t mean a form is bad — it means it needs to be dosed completely differently. MK-4 isn’t a weaker version of K2. It’s a version that demands a different strategy entirely.”
Why this isn’t simply “MK-7 good, MK-4 bad”What the research actually shows
This isn’t just theory — it’s been directly measured. A controlled study by Sato, Schurgers, and Uenishi, published in Nutrition Journal in 2012, gave healthy women consistent daily doses of either MK-4 or MK-7 and tracked what actually showed up in their blood. The result was striking: consecutive MK-4 supplementation did not meaningfully raise plasma MK-4 levels at all, while MK-7 supplementation under the same conditions significantly increased plasma MK-7 levels. In other words, taking MK-4 regularly at a standard nutritional dose barely moved the needle — while the same consistent approach with MK-7 clearly worked.
More recently, a 2026 randomized controlled trial published in JAMA Cardiology found that 360 micrograms of MK-7 daily, taken for 24 months, reduced coronary artery calcification progression by approximately 29% compared to placebo in patients with symptomatic coronary artery disease. It’s worth being precise here: this trial studied a specific population — people with existing coronary artery disease — so the finding shouldn’t be stretched into a blanket claim for everyone. But it’s a real, recent, well-controlled clinical result directly tied to K2’s calcium-direction mechanism.
The dosing gap, in plain numbers
| MK-7 | MK-4 | |
|---|---|---|
| Half-life | ~3 days (up to 72 hours) | ~1–2 hours |
| Effective daily dose | 45–90 micrograms | Milligram range (500mcg–45mg depending on use) |
| Dosing frequency needed | Once daily | Multiple times daily for sustained effect |
| Primary natural source | Fermented foods (natto), gut bacteria | Animal products; also body’s own K1 conversion |
| Best suited for | Daily supplementation, consistent long-term use | High-dose clinical/therapeutic contexts (studied in Japan for osteoporosis) |
Why this connects back to the D3 + K2 pairing
If you’ve read our guide on why D3 and K2 only work well together, this half-life story fills in a piece that page doesn’t cover: it’s not just that you need both nutrients — it’s that the form of K2 in a daily supplement determines whether it’s actually doing anything by the time you take your next dose. A D3+K2 formula built around MK-4 at a token dose would mean the K2 component is largely inactive for most of the day. A formula built around MK-7 keeps working continuously, which is the entire point of pairing the two nutrients in the first place.
MenaQ7® MK-7. Still working, hours after you’ve forgotten you took it.
EVO HOMINUS uses MenaQ7® MK-7 at 55mcg, working alongside vegan Vitashine® D3 — chosen specifically because MK-7’s long half-life means a single daily capsule keeps osteocalcin and matrix Gla protein activation going around the clock, rather than in short bursts that fade before the next dose. Consistent with the same principle behind every other active-form ingredient in the formula: what matters isn’t just what’s on the label, it’s what’s still working hours later.
What to actually take away from this
MK-7 vs MK-4, answered plainly.
More from the EVO HOMINUS knowledge hub
Vitamin D3 & K2 — Why They Only Work Together
The complete D3-K2 synergy story this page’s half-life detail fills in.
Read the guide → Science HubVitamin D Deficiency in India — Why Most of Us Are Low Despite the Sun
The other half of the calcium-absorption story, and why D3 status matters so widely in India.
Read the guide → Science HubMagnesium Glycinate vs Citrate vs Oxide — A Complete Comparison
The same “form determines what actually works” story, told for a different nutrient.
Read the guide →